Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Aceragen, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 19 | 20 | +1 |
| Shares | 168.1K | 165.4K | −2.71K (−1.6%) |
| Value | $384.8K | $269.5K | −$115.2K (−29.9%) |
New holders (1)
Institutions that held Aceragen, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caldwell Sutter Capital, Inc. | 294 | $479 | 0.00% |
Sold out (0)
Institutions that held Aceragen, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
None.